Biotech Markets Turn Positive but Experts Say Don’t Call It a Comeback—Yet

BioSpace·Oct 22

This story is reported by BioSpace. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

'It’s going to be huge': The 'diabolical' molecule poised to become biotech's next gold rush

Fierce Biotech·Apr 9

2

Earnings call transcript: Schrödinger misses EPS but beats revenue in Q1 2026

Investing.com·May 5

3

Don't buy this dip, wait for the next one, says CA Rudramurthy BV

The Economic Times·Jun 19

4

Why new wellness-branded energy drinks have health experts worried

STAT·May 13

5

Experts Say the ‘New Normal’ in 2025 Will Be Far More Tech-Driven, Presenting More Big Challenges

Pew Research Center·Feb 18

6

Biopharma leaders paving the way for LGBTQ+ scientists, patients, entrepreneurs and C-suites

Endpoints News·Jun 6

7

Trump Returns Home After Downplaying Disease, but Doctor Says He Isn’t ‘Out of the Woods’ (Published 2020)

The New York Times·May 25

8

The future of food: Scientists have found a fast and cheap way to edit your edibles’ DNA

The Washington Post·Aug 11